| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 5, 2023Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.
Medtronic plc (NYSE:MDT), a global leader in medical technology, presented multi-continent real-world data demonstrating that use of the MiniMed™ 780G system allows people living with diabetes...
-
Apr 27, 2022Results were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
Medtronic reported study results from the extended study phase of its MiniMed™ 780G system[i] pivotal trial with new data using its no-calibration, non-adjunctive Guardian™ 4 sensor[ii]. The...
-
Apr 25, 2022
Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...
-
Apr 20, 2022
Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for its advanced insulin delivery system, MiniMed 780G, has been recently expanded across two more...
